# A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

> **NCT04439799** · PHASE4 · COMPLETED · sponsor: **University of Miami** · enrollment: 81 (actual)

## Conditions studied

- Hypogonadism, Male

## Interventions

- **DRUG:** Testosterone Cypionate 200 Mg/ML
- **DRUG:** Intranasal Testosterone

## Key facts

- **NCT ID:** NCT04439799
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-07
- **Primary completion:** 2023-02-09
- **Final completion:** 2023-02-09
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2023-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04439799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04439799, "A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04439799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*